Who are TACE with Drug Eluting Beads procedure's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tace-with-drug-eluting-beads-procedure.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

TACE with Drug Eluting Beads procedure — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TACE with Drug Eluting Beads procedure (TACE with Drug Eluting Beads procedure) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Interventional oncology procedure / chemoembolization. Area: Oncology.

marketed Interventional oncology procedure / chemoembolization Oncology Small molecule Live · refreshed every 30 min

Target snapshot

TACE with Drug Eluting Beads procedure (TACE with Drug Eluting Beads procedure) — Ain Shams University. TACE with drug-eluting beads delivers chemotherapy directly to hepatocellular carcinoma tumors via arterial catheterization while blocking blood supply to the tumor.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
TACE with Drug Eluting Beads procedure TARGET	TACE with Drug Eluting Beads procedure	Ain Shams University	marketed	Interventional oncology procedure / chemoembolization

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Interventional oncology procedure / chemoembolization class)

Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TACE with Drug Eluting Beads procedure — Competitive Intelligence Brief. https://druglandscape.com/ci/tace-with-drug-eluting-beads-procedure. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab